  The product, a synthetic scaffold for bone grafts, was
developed by biomedical engineers at UTSA. The university
secured a patent for the invention and licensed the technology
back to UTSA faculty members, who formed the spinoff company
GenOsteo in 2008.  The company now has linked up with Austin-
based SpineSmith Partners, which will focus on marketing, sales
and distribution of the product. They also are seeking
investment capital and approval from the Food and Drug
Administration.  The scaffold uses adult stem cells for spinal
fusion and restoring bone lost due to trauma or disease.
GenOsteo is located in UTSA's New Venture incubator, which
serves as a bridge between San Antonio entrepreneurs and the
region's research and development community.